(Q24201643)

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Misoprostol versus oxytocin for the reduction of postpartum blood loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Oral misoprostol versus oxytocin in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Sublingual misoprostol versus methylergometrine for active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Oral misoprostol versus injectable methylergometrine in management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Oral misoprostol in the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Factors associated with acute postpartum hemorrhage in low-risk women delivering in rural India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Conducting international collaborative research in developing nations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Variation in the postpartum hemorrhage rate in a clinical trial of oral misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Side effects of oral misoprostol for the prevention of postpartum hemorrhage: results of a community-based randomised controlled trial in rural India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Misoprostol for prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Oral misoprostol for third stage of labor: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Prophylactic intramyometrial carboprost tromethamine does not substantially reduce blood loss relative to intramyometrial oxytocin at routine cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Buccal misoprostol to decrease blood loss after vaginal delivery: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

WHO multicentre randomised trial of misoprostol in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Misoprostol versus oxytocin in the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Optimization of third-stage management after second-trimester medical pregnancy termination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

The use of rectal misoprostol as active pharmacological management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

The effect of prostaglandin F2∝ on third stage labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Effect of oxytocics on prostaglandin levels in the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Postpartum intrauterine pressure studies of the uterotonic effect of oral misoprostol and intramuscular syntometrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Placebo-controlled randomized comparison of vaginal with rectal misoprostol in the prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

The effect of misoprostol on postpartum contractions: a randomised comparison of three sublingual doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Rectal versus oral misoprostol for active management of third stage of labor: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

The misoprostal third stage study: a randomised controlled comparison between orally administered misoprostol and standard management. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stag

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Active versus expectant management for women in the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Severe hyperthermia following oral misoprostol in the immediate postpartum period

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Prophylactic use of oxytocin in the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Instability of (methyl)ergometrine in tropical climates: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

WHO analysis of causes of maternal death: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Does a novel prefilled injection device make postpartum oxytocin easier to administer? Results from midwives in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Prostaglandins for prevention of postpartum haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Prostaglandins for prevention of postpartum haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Prostaglandins for preventing postpartum haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

The efficacy of oral misoprostol in preventing postpartum hemorrhage in a community setting: A randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB4

Uterine motility after post-partum application of sulprostone and other oxytocics

21 January 2018

1 reference

12 December 2020

PROPHYLACTIC USE OF 15(S)15 METHYL PGF2α BY INTRAMUSCULAR ROUTE FOR CONTROL OF POSTPARTUM BLEEDING - A COMPARATIVE TRIAL WITH METHYLERGOMETRINE.

1 reference

12 December 2020

A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour

1 reference

12 December 2020

Preventing the recurrence of atonic postpartum hemorrhage: a double-blind trial

1 reference

12 December 2020

Absorption kinetics of misoprostol with oral or vaginal administration

1 reference

12 December 2020

The circulating levels of oxytocin following intravenous and intramuscular administration of Syntometrine

1 reference

12 December 2020

A study of prophylactic use of 15-methyl prostalglandin F2alpha in the active management of third stage of labour.

1 reference

12 December 2020

Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India

1 reference

12 December 2020

A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor

1 reference

12 December 2020

Intrauterine misoprostol for the prevention of bleeding cesarean

1 reference

12 December 2020

A prospective, double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2 alpha, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section

1 reference

12 December 2020

Evaluation of two uterotonic medications for the management of the third stage of labor

1 reference

12 December 2020

A randomized controlled study of prostaglandin 15-methyl F2 alpha compared with syntometrine for prophylactic use in the third stage of labour

1 reference

12 December 2020

PROPHYLACTIC USE OF 15(S)15 METHYL PGF2α , BY INTRAMUSCULAR ROUTE - A CONTROLLED CLINICAL TRIAL.

1 reference

12 December 2020

The effects of intramyometrial injection of prostaglandin F2α on severe post-partum hemorrhage

1 reference

12 December 2020

Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial.

1 reference

12 December 2020

Carboprost trometamol in the management of the third stage of labor

1 reference

12 December 2020

Rectal misoprostol versus oxytocin in the prevention of postpartum hemorrhage - A pilot study

1 reference

12 December 2020

PROPHYLACTIC USE OF 15(S)15 METHYL PGF2α FOR CONTROL OF POSTPARTUM BLEEDING.

1 reference

12 December 2020

Dinoprostone vaginal insert versus intravenous oxytocin to reduce postpartum blood loss following vaginal or cesarean delivery

1 reference

12 December 2020

Side-effects of oral misoprostol in the third stage of labour--a randomised placebo-controlled trial

1 reference

12 December 2020

Oral misoprostol for the third stage of labor: a randomized controlled trial

1 reference

12 December 2020

A randomized comparison of rectal misoprostol with syntometrine on blood loss in the third stage of labour.

1 reference

12 December 2020

A preliminary study of cutaneous blood flow associated with postpartum use of oral misoprostol

1 reference

12 December 2020

Use of oral misoprostol in the prevention of postpartum haemorrhage

1 reference

12 December 2020

Use of 15-methyl prostaglandin F2 alpha postpartum to contract the uterus in normal pregnant women

1 reference

12 December 2020

Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour.

1 reference

12 December 2020

Randomized comparison of rectal misoprostol with Syntometrine for management of third stage of labor

1 reference

12 December 2020

Misoprostol dose-related shivering and pyrexia in the third stage of labour. WHO Collaborative Trial of Misoprostol in the Management of the Third Stage of Labour.

1 reference

12 December 2020

1 reference

12 December 2020

Effect of intraumbilical prostaglandin F2 alpha injection on the third stage of labor

1 reference

12 December 2020

Sublingual misoprostol for the prevention of postpartum hemorrhage.

1 reference

12 December 2020

Role of misoprostol in the delivery outcome

1 reference

12 December 2020

Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects

1 reference

12 December 2020

The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management

1 reference

12 December 2020

Rectal misoprostol versus oxytocin in the management of the third stage of labour.

1 reference

12 December 2020

Rectal misoprostol vs. 15-methyl prostaglandin F2alpha for the prevention of postpartum hemorrhage

1 reference

12 December 2020

A double-blind randomized controlled trial to compare sublingual misoprostol with methylergometrine for prevention of postpartum hemorrhage

1 reference

12 December 2020

[Clinical study on reduction of postpartum bleeding by methyl carprost suppository]

1 reference

12 December 2020

A randomised placebo controlled trial of oral misoprostol in the third stage of labour

1 reference

12 December 2020

Preliminary progress report: Randomized double-blind trial of Zhi Byed 11 , a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet

1 reference

12 December 2020

[Reduced post-partum bleeding after treatment with sublingual misoprostol: a randomized double-blind clinical study in a developing country--secondary publication)]

1 reference

12 December 2020

10.1002/14651858.CD000494.PUB4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4024276

4024276

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference